FDA Guidance on Conduct of Clinical Trials of Medical Products During the Public Health Emergency

OSI’s Role in the Drug Development Process and Impact of COVID-19Подробнее

OSI’s Role in the Drug Development Process and Impact of COVID-19

Updated FDA Guidance on Clinical Trial Conduct During COVID-19Подробнее

Updated FDA Guidance on Clinical Trial Conduct During COVID-19

EPISODE 14: Conduct of Clinical Trials of Medical Products during COVID-19 Public Health EmergencyПодробнее

EPISODE 14: Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency

MDA Advocacy Institute Session 2: COVID-19 Discussion with the FDAПодробнее

MDA Advocacy Institute Session 2: COVID-19 Discussion with the FDA

EPISODE 6: Statistical Considerations for Clinical Trials During COVID-19 Public Health EmergencyПодробнее

EPISODE 6: Statistical Considerations for Clinical Trials During COVID-19 Public Health Emergency